CAR T Cell Therapy: Engineering the Immune System to Fight Pediatric Cancer
Take a closer look at the role of T cells in cancer therapy and the development of chimeric antigen receptor (CAR) T cells. Explore the early successes and challenges in the development of CAR T cell therapy in pediatric leukemia. Presented by Dr. Amanda Li, Clinical Assistant Professor, Department of Pediatrics, UBC; Attending Physician, BC Children's Hospital. (2019)
A new study led by researchers from the BC Injury Research and Prevention Unit found girls in rural B.C. communities with poor access to local mental health services are at the highest risk of intentionally poisoning themselves. The most common substance used was non-opioid painkillers and the second most common substance used was medication for anxiety and depression.
Dr. Pascal Lavoie and his team compared the immune responses of babies to those of COVID-19-negative adults from Metro Vancouver. The antibody reactivity to SARS-CoV-2 in almost all of these adults was up to 100-fold higher compared to the infants at second blood sera collection. The researchers estimate that between 90-99 per cent of adults have positive antibody reactivity to SARS-CoV-2 antigens.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.